KhaledArefHassanMDMS

Oncology • Cleveland, OH

Hematologic Oncology, Thoracic Cancer

Physician

Join to view full profile

Dr. Hassan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hassan's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 216-445-9365

Summary

Dr. Khaled Hassan is an oncologist in Cleveland, OH and is affiliated with multiple hospitals in the area, including Michigan Medicine, Veterans Affairs Ann Arbor Healthcare System, and Cleveland Clinic. He received his medical degree from Kursk State Medical University and has been in practice 19 years. He specializes in hematologic oncology and thoracic cancer and is experienced in thoracic oncology.

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2006 - 2009
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 2003 - 2006
Kursk State Medical UniversityClass of 1998

Certifications & Licensure

OH State Medical License 2014 - 2026
MI State Medical License 2006 - 2020
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

44 citations
Implication of Protein Kinase B/Akt and Bcl-2/Bcl-XL Suppression by the Farnesyl Transferase Inhibitor SCH66336 in Apoptosis Induction in Squamous Carcinoma Cells
Kyung Hee Chun, Ho-Young Lee, Khaled A. Hassan, Fadlo R. Khuri, Waun Ki Hong
Cancer Research. 2003-08-15
53 citations
High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients.
Mina Zeinali, Maggie Lee, Arthi Nadhan, Anvya Mathur, Casey Hedman
Cancers. 2020-01-03
26 citations
Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel
Journal of the National Comprehensive Cancer Network. 2021-04-20

Journal Articles

The EGFR T790M Mutation Is Acquired Through AICDA-Mediated Deamination of 5-Methylcytosine Following TKI Treatment in Lung Cancer
Gregory P Kalemkerian, Khaled A Hassan, Clinical Cancer Research

Press Mentions

Nurturing Integrated Diagnostics in OncologyJanuary 20th, 2022
OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerSeptember 24th, 2019
Early Diagnosis and Significant Advances in Treatment Could Reduce High Lung Cancer Death Rate, Says Cleveland Clinic ExpertAugust 1st, 2023